nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Mesalazine—PPARG—thyroid cancer	0.0231	0.51	CrCbGaD
Droxidopa—Aminosalicylic Acid—PTGS2—thyroid cancer	0.0124	0.274	CrCbGaD
Droxidopa—Mesalazine—PTGS2—thyroid cancer	0.00975	0.215	CrCbGaD
Droxidopa—Myocardial ischaemia—Sorafenib—thyroid cancer	0.00751	0.0991	CcSEcCtD
Droxidopa—Blood pressure increased—Sorafenib—thyroid cancer	0.00603	0.0797	CcSEcCtD
Droxidopa—Urinary tract infection—Vandetanib—thyroid cancer	0.00486	0.0642	CcSEcCtD
Droxidopa—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00483	0.0638	CcSEcCtD
Droxidopa—Arrhythmia—Vandetanib—thyroid cancer	0.00401	0.053	CcSEcCtD
Droxidopa—Loss of consciousness—Vandetanib—thyroid cancer	0.00344	0.0454	CcSEcCtD
Droxidopa—Hypertension—Vandetanib—thyroid cancer	0.00338	0.0446	CcSEcCtD
Droxidopa—Arrhythmia—Sorafenib—thyroid cancer	0.00271	0.0357	CcSEcCtD
Droxidopa—Syncope—Sorafenib—thyroid cancer	0.00237	0.0312	CcSEcCtD
Droxidopa—Loss of consciousness—Sorafenib—thyroid cancer	0.00232	0.0306	CcSEcCtD
Droxidopa—Hypertension—Sorafenib—thyroid cancer	0.00228	0.0301	CcSEcCtD
Droxidopa—Shock—Sorafenib—thyroid cancer	0.00212	0.028	CcSEcCtD
Droxidopa—Dizziness—Vandetanib—thyroid cancer	0.00211	0.0279	CcSEcCtD
Droxidopa—Headache—Vandetanib—thyroid cancer	0.002	0.0264	CcSEcCtD
Droxidopa—Nausea—Vandetanib—thyroid cancer	0.0019	0.025	CcSEcCtD
Droxidopa—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00178	0.0236	CcSEcCtD
Droxidopa—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00165	0.0218	CcSEcCtD
Droxidopa—Dizziness—Sorafenib—thyroid cancer	0.00142	0.0188	CcSEcCtD
Droxidopa—Headache—Sorafenib—thyroid cancer	0.00135	0.0178	CcSEcCtD
Droxidopa—Nausea—Sorafenib—thyroid cancer	0.00128	0.0169	CcSEcCtD
Droxidopa—Urinary tract infection—Epirubicin—thyroid cancer	0.00121	0.016	CcSEcCtD
Droxidopa—Urinary tract infection—Doxorubicin—thyroid cancer	0.00112	0.0148	CcSEcCtD
Droxidopa—Arrhythmia—Epirubicin—thyroid cancer	0.001	0.0132	CcSEcCtD
Droxidopa—Arrhythmia—Doxorubicin—thyroid cancer	0.000925	0.0122	CcSEcCtD
Droxidopa—Syncope—Epirubicin—thyroid cancer	0.000874	0.0115	CcSEcCtD
Droxidopa—Loss of consciousness—Epirubicin—thyroid cancer	0.000857	0.0113	CcSEcCtD
Droxidopa—Hypertension—Epirubicin—thyroid cancer	0.000842	0.0111	CcSEcCtD
Droxidopa—Syncope—Doxorubicin—thyroid cancer	0.000809	0.0107	CcSEcCtD
Droxidopa—Confusional state—Epirubicin—thyroid cancer	0.000802	0.0106	CcSEcCtD
Droxidopa—Loss of consciousness—Doxorubicin—thyroid cancer	0.000793	0.0105	CcSEcCtD
Droxidopa—Shock—Epirubicin—thyroid cancer	0.000783	0.0103	CcSEcCtD
Droxidopa—Hypertension—Doxorubicin—thyroid cancer	0.000779	0.0103	CcSEcCtD
Droxidopa—Confusional state—Doxorubicin—thyroid cancer	0.000742	0.0098	CcSEcCtD
Droxidopa—Shock—Doxorubicin—thyroid cancer	0.000724	0.00956	CcSEcCtD
Droxidopa—Feeling abnormal—Epirubicin—thyroid cancer	0.000656	0.00865	CcSEcCtD
Droxidopa—Feeling abnormal—Doxorubicin—thyroid cancer	0.000607	0.00801	CcSEcCtD
Droxidopa—ADRA2C—Signaling by GPCR—CDK1—thyroid cancer	0.000534	0.000608	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CALCA—thyroid cancer	0.000528	0.000601	CbGpPWpGaD
Droxidopa—Dizziness—Epirubicin—thyroid cancer	0.000526	0.00694	CcSEcCtD
Droxidopa—ADRA1B—Signaling by GPCR—CDK1—thyroid cancer	0.000526	0.000598	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MEN1—thyroid cancer	0.000519	0.000591	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TCF7L1—thyroid cancer	0.000517	0.000588	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CALCA—thyroid cancer	0.000516	0.000587	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PPARG—thyroid cancer	0.000509	0.00058	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TSHR—thyroid cancer	0.000503	0.000573	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TSHR—thyroid cancer	0.000499	0.000568	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000498	0.000567	CbGpPWpGaD
Droxidopa—Headache—Epirubicin—thyroid cancer	0.000498	0.00658	CcSEcCtD
Droxidopa—ADRA2A—Signaling by GPCR—SST—thyroid cancer	0.000498	0.000567	CbGpPWpGaD
Droxidopa—PAH—Disease—KRAS—thyroid cancer	0.000495	0.000564	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000495	0.000563	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TSHR—thyroid cancer	0.000492	0.00056	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PRKAR1A—thyroid cancer	0.000491	0.000558	CbGpPWpGaD
Droxidopa—Dizziness—Doxorubicin—thyroid cancer	0.000487	0.00643	CcSEcCtD
Droxidopa—ADRB2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000484	0.000551	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CALCA—thyroid cancer	0.00048	0.000546	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000477	0.000543	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MEN1—thyroid cancer	0.000473	0.000538	CbGpPWpGaD
Droxidopa—Nausea—Epirubicin—thyroid cancer	0.000473	0.00624	CcSEcCtD
Droxidopa—ADRA1D—Signaling Pathways—PTCH1—thyroid cancer	0.00047	0.000534	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MEN1—thyroid cancer	0.000469	0.000534	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CDK1—thyroid cancer	0.000467	0.000532	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TSHR—thyroid cancer	0.000466	0.00053	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MEN1—thyroid cancer	0.000463	0.000527	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NRG1—thyroid cancer	0.000461	0.000525	CbGpPWpGaD
Droxidopa—Headache—Doxorubicin—thyroid cancer	0.000461	0.00609	CcSEcCtD
Droxidopa—ADRA1B—Signaling Pathways—TSHR—thyroid cancer	0.000459	0.000522	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PRKAR1A—thyroid cancer	0.000458	0.000522	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—TPR—thyroid cancer	0.000453	0.000515	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PRKAR1A—thyroid cancer	0.000451	0.000513	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000448	0.00051	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PRKAR1A—thyroid cancer	0.000445	0.000507	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MEN1—thyroid cancer	0.000438	0.000498	CbGpPWpGaD
Droxidopa—Nausea—Doxorubicin—thyroid cancer	0.000437	0.00577	CcSEcCtD
Droxidopa—ADRA2A—Signaling by GPCR—CDK1—thyroid cancer	0.000434	0.000494	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MEN1—thyroid cancer	0.000431	0.000491	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SST—thyroid cancer	0.00043	0.000489	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTCH1—thyroid cancer	0.000428	0.000487	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTCH1—thyroid cancer	0.000424	0.000483	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000424	0.000482	CbGpPWpGaD
Droxidopa—PAH—Disease—HRAS—thyroid cancer	0.000421	0.000479	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTCH1—thyroid cancer	0.000419	0.000476	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000419	0.000476	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—SLC5A5—thyroid cancer	0.000417	0.000475	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TERT—thyroid cancer	0.000414	0.000471	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CALCA—thyroid cancer	0.000414	0.000471	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TSHR—thyroid cancer	0.000407	0.000463	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000401	0.000456	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTGS2—thyroid cancer	0.000401	0.000456	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTCH1—thyroid cancer	0.000396	0.000451	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—HIF1A—thyroid cancer	0.000396	0.000451	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SST—thyroid cancer	0.000392	0.000445	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTCH1—thyroid cancer	0.00039	0.000444	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SST—thyroid cancer	0.000388	0.000441	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MEN1—thyroid cancer	0.000383	0.000436	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SST—thyroid cancer	0.000383	0.000436	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TSHR—thyroid cancer	0.000378	0.000431	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CALCA—thyroid cancer	0.000377	0.000429	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDK1—thyroid cancer	0.000374	0.000426	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CALCA—thyroid cancer	0.000373	0.000425	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PRKAR1A—thyroid cancer	0.000372	0.000424	CbGpPWpGaD
Droxidopa—PAH—Disease—AKT1—thyroid cancer	0.000372	0.000423	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CALCA—thyroid cancer	0.000369	0.000419	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SST—thyroid cancer	0.000362	0.000412	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—NRAS—thyroid cancer	0.000358	0.000407	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SST—thyroid cancer	0.000357	0.000406	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	0.000356	0.000405	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—RXRA—thyroid cancer	0.00035	0.000399	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTEN—thyroid cancer	0.000349	0.000398	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—NRAS—thyroid cancer	0.000349	0.000397	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CALCA—thyroid cancer	0.000349	0.000397	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	0.000346	0.000394	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CALCA—thyroid cancer	0.000343	0.000391	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDK1—thyroid cancer	0.000341	0.000388	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.00034	0.000387	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—SLC5A5—thyroid cancer	0.000339	0.000385	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDK1—thyroid cancer	0.000338	0.000385	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—NRAS—thyroid cancer	0.000334	0.00038	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDK1—thyroid cancer	0.000334	0.00038	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—BRAF—thyroid cancer	0.000328	0.000373	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	0.000322	0.000366	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SST—thyroid cancer	0.000317	0.00036	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDK1—thyroid cancer	0.000316	0.000359	CbGpPWpGaD
Droxidopa—PAH—Metabolism—AKT1—thyroid cancer	0.000311	0.000354	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDK1—thyroid cancer	0.000311	0.000354	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—KRAS—thyroid cancer	0.000308	0.00035	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	0.000305	0.000347	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NRG1—thyroid cancer	0.000301	0.000342	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—KRAS—thyroid cancer	0.0003	0.000342	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SST—thyroid cancer	0.000294	0.000335	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—KRAS—thyroid cancer	0.000288	0.000327	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—RXRA—thyroid cancer	0.000285	0.000324	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	0.000283	0.000322	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	0.000276	0.000314	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NRG1—thyroid cancer	0.000274	0.000312	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TP53—thyroid cancer	0.000274	0.000311	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—NRAS—thyroid cancer	0.000271	0.000309	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	0.000271	0.000309	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TERT—thyroid cancer	0.00027	0.000307	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NRG1—thyroid cancer	0.000268	0.000305	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—HRAS—thyroid cancer	0.000262	0.000298	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—HIF1A—thyroid cancer	0.000258	0.000294	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	0.000256	0.000292	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TP53—thyroid cancer	0.000256	0.000291	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—HRAS—thyroid cancer	0.000255	0.00029	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NRG1—thyroid cancer	0.000253	0.000288	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	0.000249	0.000284	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—AKT1—thyroid cancer	0.000248	0.000282	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TERT—thyroid cancer	0.000246	0.00028	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—HRAS—thyroid cancer	0.000244	0.000278	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TERT—thyroid cancer	0.000244	0.000277	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TERT—thyroid cancer	0.00024	0.000274	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCND1—thyroid cancer	0.000239	0.000272	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—HIF1A—thyroid cancer	0.000235	0.000267	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—KRAS—thyroid cancer	0.000234	0.000266	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	0.000233	0.000265	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PTEN—thyroid cancer	0.000231	0.000263	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—AKT1—thyroid cancer	0.000231	0.000263	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—HIF1A—thyroid cancer	0.00023	0.000262	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TERT—thyroid cancer	0.000228	0.000259	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—NRAS—thyroid cancer	0.000227	0.000259	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AKT1—thyroid cancer	0.000225	0.000256	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TERT—thyroid cancer	0.000224	0.000255	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	0.000222	0.000252	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PPARG—thyroid cancer	0.000221	0.000252	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	0.000218	0.000248	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—AKT1—thyroid cancer	0.000216	0.000246	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	0.000214	0.000244	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	0.000214	0.000243	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—thyroid cancer	0.000208	0.000236	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—NRAS—thyroid cancer	0.000207	0.000236	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NRAS—thyroid cancer	0.000206	0.000235	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	0.000206	0.000234	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	0.000205	0.000234	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—NRAS—thyroid cancer	0.000203	0.000231	CbGpPWpGaD
Droxidopa—DDC—Metabolism—AKT1—thyroid cancer	0.000201	0.000229	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TERT—thyroid cancer	0.000199	0.000226	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—HRAS—thyroid cancer	0.000199	0.000226	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	0.000196	0.000223	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—BRAF—thyroid cancer	0.000195	0.000222	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	0.000193	0.000219	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	0.000192	0.000218	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—BRAF—thyroid cancer	0.00019	0.000217	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	0.00019	0.000216	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	0.000189	0.000215	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TERT—thyroid cancer	0.000185	0.00021	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	0.00018	0.000205	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPARG—thyroid cancer	0.00018	0.000204	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—KRAS—thyroid cancer	0.000178	0.000203	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—KRAS—thyroid cancer	0.000177	0.000202	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	0.000177	0.000202	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	0.000177	0.000201	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	0.000177	0.000201	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—AKT1—thyroid cancer	0.000175	0.000199	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—KRAS—thyroid cancer	0.000174	0.000198	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—thyroid cancer	0.000174	0.000198	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	0.000168	0.000191	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	0.000166	0.000189	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	0.000165	0.000188	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	0.000162	0.000185	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	0.000162	0.000184	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—thyroid cancer	0.000158	0.000179	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	0.000158	0.000179	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	0.000156	0.000177	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	0.000156	0.000177	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTEN—thyroid cancer	0.000152	0.000173	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—HRAS—thyroid cancer	0.000152	0.000172	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—HRAS—thyroid cancer	0.000151	0.000172	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	0.000151	0.000171	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	0.00015	0.000171	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—HRAS—thyroid cancer	0.000148	0.000169	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AKT1—thyroid cancer	0.000147	0.000168	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	0.000147	0.000167	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	0.000146	0.000167	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	0.000146	0.000166	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	0.000144	0.000164	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AKT1—thyroid cancer	0.000144	0.000164	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCND1—thyroid cancer	0.000142	0.000162	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—thyroid cancer	0.000141	0.000161	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	0.000141	0.00016	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	0.00014	0.00016	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCND1—thyroid cancer	0.000139	0.000158	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	0.000138	0.000157	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTEN—thyroid cancer	0.000137	0.000156	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	0.000136	0.000155	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	0.000136	0.000155	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	0.000134	0.000153	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	0.000134	0.000153	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTEN—thyroid cancer	0.000134	0.000153	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	0.000134	0.000152	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AKT1—thyroid cancer	0.000134	0.000152	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AKT1—thyroid cancer	0.000133	0.000152	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	0.000133	0.000151	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	0.000132	0.00015	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AKT1—thyroid cancer	0.000131	0.000149	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	0.000129	0.000147	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	0.000127	0.000144	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	0.000125	0.000142	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	0.000124	0.000141	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTEN—thyroid cancer	0.000123	0.00014	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	0.000123	0.000139	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NRAS—thyroid cancer	0.000122	0.000139	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	0.000122	0.000139	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	0.000121	0.000138	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NRAS—thyroid cancer	0.00012	0.000136	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	0.000119	0.000136	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	0.000116	0.000132	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	0.000115	0.000131	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	0.000114	0.00013	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	0.000113	0.000129	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	0.000111	0.000127	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	0.000111	0.000126	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	0.000111	0.000126	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	0.000108	0.000123	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	0.000107	0.000122	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—KRAS—thyroid cancer	0.000105	0.00012	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	0.000104	0.000119	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	0.000103	0.000117	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—KRAS—thyroid cancer	0.000103	0.000117	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—thyroid cancer	0.000103	0.000117	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	0.000101	0.000114	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	9.9e-05	0.000113	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	9.82e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	9.75e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	9.59e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—thyroid cancer	9.36e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—thyroid cancer	9.27e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	9.2e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—thyroid cancer	9.16e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—HRAS—thyroid cancer	8.95e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	8.87e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—HRAS—thyroid cancer	8.76e-05	9.96e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AKT1—thyroid cancer	8.75e-05	9.95e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	8.67e-05	9.87e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—thyroid cancer	8.66e-05	9.86e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—thyroid cancer	8.53e-05	9.7e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	8.52e-05	9.69e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	8.29e-05	9.43e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	8.15e-05	9.28e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	7.92e-05	9.01e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AKT1—thyroid cancer	7.9e-05	8.99e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	7.83e-05	8.91e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AKT1—thyroid cancer	7.73e-05	8.8e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—thyroid cancer	7.57e-05	8.62e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	7.32e-05	8.32e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	7.24e-05	8.24e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	7.2e-05	8.19e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AKT1—thyroid cancer	7.11e-05	8.09e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—thyroid cancer	7.04e-05	8.01e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	6.73e-05	7.66e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	6.4e-05	7.28e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	5.94e-05	6.76e-05	CbGpPWpGaD
